Novo Nordisk, a leading global healthcare company, and Amazon Web Services (AWS) today announced a strategic partnership to accelerate drug discovery and modernize operations through AI and cloud technologies. The agreement establishes AWS as Novo Nordisk’s preferred cloud provider and strategic AI partner, bringing together Novo Nordisk’s deep therapeutic expertise across serious chronic diseases with AWS’s cloud and AI services, secure infrastructure, and purpose-built life sciences technologies.
The partnership deepens a broader relationship between Novo Nordisk and Amazon. Novo Nordisk already collaborates with Amazon Pharmacy, Amazon Ads, and Amazon One Medical to transform how therapies are marketed and delivered to patients. This strategic agreement with AWS adds the technology and AI foundation that will power Novo Nordisk’s next generation of scientific discovery and operational efficiency across its global workforce of more than 66,700 people in 80…
